Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Postoperative hepatitis - Biotech, Pharma and Life Science Channel

15:16 EDT 30th July 2014 | BioPortfolio

PubMed Articles [3807 Associated PubMed Articles listed on BioPortfolio]

Simeprevir (Olysio) for chronic hepatitis c.

Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvant.

In this study, the effect and mechanisms of curdlan sulfate (CS3) on hepatitis B virus (HBV) infection and promoting immune response of the mice immunized with recombinant hepatitis B surface protein...

A comparison of the thermal inactivation kinetics of human norovirus surrogates and hepatitis A virus in buffered cell culture medium.

Human noroviruses and hepatitis A virus (HAV) are considered as epidemiologically significant causes of foodborne disease. Therefore, studies are needed to bridge existing data gaps and determine appr...

Endometrial Receptivity and Intrauterine Adhesive Disease.

Intrauterine adhesions (IUA) can occur after mechanical or infectious injury to the endometrium. Normal endometrial repair occurs without scar formation; however, in some women, these normal repair me...

Simplified technique for reconstruction of the digestive tract after total and subtotal gastrectomy for gastric cancer.

Laparoscopic surgery has been increasingly applied to gastric cancer surgery. Gastrointestinal tract reconstruction totally done by laparoscopy also has been a challenge for those who developed this p...

MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants.

110 Implementation of a Standardized Multimodal Postoperative Pain Protocol Reduces Postoperative Pain Among Neurosurgical Patients.

It is well established that postoperative pain has far reaching effects on patient physiology and length of stay. However, recent CMS initiatives such as the HCAHP survey have forced hospitals and neu...

Association between infection of hepatitis B virus and onset risk of B-cell non-Hodgkin's lymphoma: a systematic review and a meta-analysis.

Whether an association between hepatitis B virus (HBV) infection and B-cell non-Hodgkin's lymphoma (B-NHL) risk exists is an open question. In order to provide quantification of the issue, we carried...

Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma.

Men with organ-confined prostate cancer (CaP) are often treated with radical prostatectomy. Despite similar postoperative characteristics, a significant proportion of men with an intermediate risk of...

Prevention of renal dysfunction in postoperative elderly patients.

To describe the effect of ageing on kidney function and to summarize the benefits of advocated measures to prevent perioperative acute kidney injury (AKI) in elderly patients.

News Articles [1481 Associated News Articles listed on BioPortfolio]

Several Insurers Report Lower Profits

WellPoint and Humana say higher expenses kept profits down in the second quarter. The Wall Street Journal: WellPoint Profit Slips, But Boosts Outlook WellPoint Inc. on Wednesday said its second-q...

California Healthcare Institute (CHI) Releases Report Highlighting Public Impact Of Hepatitis C, Opportunities For Action In U.S.

Humana says profit fell on health reform, drug costs

(Reuters) - U.S. health insurer Humana Inc said on Wednesday that second-quarter profit fell due to investments in the exchanges created under President Barack Obama's healthcare reform law as well as...

UPDATE 1-Humana says profit fell on health reform, drug costs

July 30 (Reuters) - U.S. health insurer Humana Inc said on Wednesday that second-quarter profit fell due to investments in the exchanges created under President Barack Obama's healthcare reform law as...

Humana says quarterly profit fell on health reform, drug costs

July 30 (Reuters) - U.S. health insurer Humana Inc said on Wednesday that second-quarter profit fell due to investments in the insurance exchanges created under President Barack Obama's healthcare ref...

Gilead's Massive Undervaluation: A Pictorial Overview

By Bret Jensen:My regular readers that follow me on Real Money Pro, Seeking Alpha or recently Investors Alley over the past six months know what a huge bull I am on Gilead Sciences (NASDAQ:GILD). Not...

CHI Releases Report Highlighting Public Impact of Hepatitis C, Opportunities for Action in US

New Treatments Can Significantly Transform the Face of Hep C LA JOLLA, Calif. (PRWEB) July 29, 2014 CHI-California Healthcare Institute today unveiled a report that provides a comprehensive overview...

New online awareness campaign launched for the thousands of South Asians affected by potentially fatal disease

Multi-lingual online platform seeks to educate at-risk South Asian and Somali communities in the UK about hepatitis C.  Today marks the launch of  ‘Hepatitis C: Find the Facts’, an online platf...

Phase 2 COSMOS study results published in The Lancet demonstrate efficacy and safety of Janssen’s once-daily imeprevir

... in all oral 12-week combination with sofosbuvir for genotype 1 chronic hepatitis C.

New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015

WASHINGTON, July 29, 2014 /PRNewswire-USNewswire/ -- New high priced hepatitis C drugs will increase federal spending in Medicare Part D by a projected $2.9 to $5.8 billion next year, according to a n...

Events [0 Results]

None

Companies [25 Associated Companies listed on BioPortfolio]

Cardax, Inc.

Cardax is a development stage life sciences company that devotes substantially all of its efforts to developing nutraceutical and pharmaceutical products that provide the anti-inf...

Ichor Medical Systems, Inc.

Ichor Medical Systems’ TriGrid™ Delivery System (TriGrid) is the first integrated and fully automated device for electroporation-mediated DNA administration in humans. I...

Okairos

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, influenza, respiratory syncytial...

Profectus BioSciences, Inc.

Profectus BioSciences, Inc. is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases with a goal of reducing morbidity and mo...

ISICR

The International Society for Interferon and Cytokine Research (ISICR), based in Bethesda, Md., is a non-profit organization devoted to interferon, cytokine and chemokine r...

Viropro

Viropro Inc. (“Viropro”) operates through Viropro International Inc., a Canadian company with its Head Office in Montreal. Viropro International Inc. is specialized in the technology transfer, fo...

Enanta Pharmaceuticals, Inc.

Enanta Phatmaceuticals ARE A RESEARCH AND DEVELOPMENT-FOCUSED BIOTECHNOLOGY COMPANY that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in t...

Cardax Pharmaceuticals

Cardax is a development stage life sciences company that devotes substantially all of its efforts to developing nutraceutical and pharmaceutical products that provide the anti-inf...

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

Idenix Pharmaceuticals, Inc.

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Ide...

Clinical Trials [1795 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

The purpose of this study is to assess the efficacy of a short course of therapy (24 weeks) versus standard 48 week treatment in previously untreated adult participants with chronic hepati...

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive Chronic Hepatitis B in Vietnam

This prospective, multicenter, observational study will evaluate the sustained r esponse in patients with HBeAg positive chronic hepatitis B who are treated with Pegasys according to stand...

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

This study will determine the HCV antiviral efficacy, safety, and tolerability of treatment with Ledipasvir/Sofosbuvir (LDV/SOF) fixed-dose combination (FDC) for participants with genotype...

Randomised Study Comparing Discharge 3 Days After Surgery to Home Within 24 Hours After Laparoscopic Hysterectomy.

Hysterectomy is one of the most performed surgery in gynecologic surgery. Actually, 70 000 hysterectomies are performed each year in France. Laparoscopic surgery is in progression. The per...

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

This single arm study will investigate the predictive value of a week 4 virologi cal response on sustained virological response in patients with chronic hepatiti s C, genotype 2 or 3, trea...

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

Aim of the study is to assess the efficacy and safety of 24 weeks of oral Sofosbuvir/Ledipasvir fixed-dose combination (FDC) in subjects with HCV genotype 1 infection and HIV co-infection,...

In-hospital Physiotherapy for Patients Undergoing Thoracic Surgery - a Randomized Controlled Trial

Lung cancer is one of the most common types of cancer in the world, and the cancer that causes the most number of deaths. In Sweden, about 3700 persons are diagnosed every year. About one...

Magnesium and Rotational Thromboelastometry (ROTEM) in Colorectal Cancer Surgery

Magnesium sulphate is given to the patients during the colorectal cancer surgery under the hypothesis that it would attenuate the postoperative hypercoagulability. The investigators intend...

USG Nerve Blocks for ACL Reconstruction

Anterior cruciate ligament reconstruction is a routine surgical procedure. Traditional femoral/sciatic block combinations effectively reduce postoperative pain, but results in considerable...

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

Background: - Some people who have chronic hepatitis C do not respond to the usual treatment with peginterferon and ribavirin. New chronic hepatitis treatments are being developed that ma...

Medical and Biotech [MESH] Definitions

INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D).

A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus (HEPATITIS B VIRUS, DUCK), heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus (HEPATITIS B VIRUS, WOODCHUCK).

A species in the genus HEPATOVIRUS containing one serotype and two strains: HUMAN HEPATITIS A VIRUS and Simian hepatitis A virus causing hepatitis in humans (HEPATITIS A) and primates, respectively.

INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Search BioPortfolio:
Advertisement
Advertisement
review and buy Postoperative hepatitis market research data and corporate reports here

Channels Quicklinks